On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

Today's health news includes scientists' reactions to RFK Jr.'s nomination as HHS secretary and a CAR-T therapy for a deadly ...

Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...

The death of Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, was caused by an ...

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

RFK Jr.'s 'Make America Healthy Again' agenda focuses on overhauling health care and food to combat chronic disease ...

A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

Reporters @statnews asked leaders in the life sciences commuity for reactions to RFK Jr.'s selection as health secretary. Many were aghast, while others played down the news.

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.